The International Society for Stem Cell Application (ISSCA) is hosting the most anticipated regenerative medicine event of he year – Regenerative Medicine World Congress 2022. The congress will take place at the Radisson Blu Hotel Istanbul Sisli, Turkey, on September 23. 24. and 25. 

The congress features theoretical lectures on the first two days. Physicians and scientists from around the world will present evidence-based research: demonstrate updates on technologies. products, and equipment: share their extensive experience in clinical applications of regenerative medicine and cellular therapies. 30 presentations focusing on stem cell research and regenerative medicine will be given by clinicians and researchers in different specialties. Featured topics include: 

• Mesenchymal stem cells (MSC) 
• Exosomes
• Plastic and reconstructive surgery
• Clinical trials
• Nerve injury treatment
• Applications in ophthalmology and cardiology
• Immunotherapy

The congress will be the ultimate gathering and a showcase of the most cutting-edge research in regenerative medicine. Congress participants will be able to network with like-minded medical professionals from different parts of the world and become part of a growing community leading the future of medicine. 

With the All-Access package, congress participants will have access to the hands-on practice certification portion on the third day. The live practical portion has only 20 limited seats available.

ISSCA-certified instructors, Dr. Maritza Novas (Director of Research and Development at Global Stem Cells Group. USA) and Dr. Melihcan Sezgic (Plastic. Reconstructive and Aesthetic Surgeon. Regenerative Medicine Specialist. Turkey), will lead one-on-one training sessions at the ReGeniC Clinic. This is a great opportunity to gain intensive hands-on experience in the aesthetic and clinical applications of stem cell therapy. The following training modules are included: 

Cellular Products 

1. Mononuclear layer umbilical cord blood
2. Exosomes: Characterization, examination of growth factors and cytokines
3. Amniotic fluid and its action as a natural anti-inflammatory 

Production, Manufacturing, and Quality Control 

1. Eligibility and selection of donors
2. Collection and management of samples
3. Processing and laboratory standards
4. Testing and validation of quality control 

Protocol Discussion 

1. Clinical framework for therapeutic applications 
2. Protocol details and supporting scientific literature
3. Product storage and preparation
4. Selection of patients
5. Results and expectations of patients 

Application of the Protocol in Live Patients

1. Demonstration of product preparation and injection

About ISSCA 

The ISSCA is a multidisciplinary community of physicians and scientists with a mission to advance the science, technology, and practice of Regenerative Medicine to treat disease and lessen human suffering. Its members are leaders in setting standards and promoting excellence in regenerative medicine, related education, certification, research and publications. 

The Regenerative Medicine World Congress 2022 will be one of the most celebrated events of the year. where we share the ISSCA values in Integrity, Interdisciplinary, and Innovation. The ISSCA invites physicians and healthcare professionals devoted to regenerative medicine to expand their network, access world-class speakers, and update themselves with the latest technologies, products and equipment.

For more information. please fill out the form to contact us.